Basic Information
ID: ALA4606542
Type: Functional
Description: Protection against reactivation of type 2 Toxoplasma gondii ME49 infection in sulfadiazin-treated Ifngr1-/- CD1 mouse assessed as reduction in parasite infection at 60 mg/kg, po administered twice daily via gavage for 8 days measured up to 30 days by luciferase reporter gene based bioluminescence assay
Organism: Toxoplasma gondii
Strain: ME49
Activity Charts
Bioactivity
Activity Types for Assay ALA4606542
Activity
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 336.28 | 2.95 | 2.95 |